CMap Candidates
CMap (Connectivity Map) candidates are extracted from CLUE (CMap and LINCS Unified Environment), with detailed information, e.g., perturbagen time and dose, compound structure, targets, SMILES, mechanism of action. Two publicly available gene expression profiles of NAFLD are used to calculate individual connectivity scores and corresponding statistical significances for these candidates.
stats1
stats2
34330 records.
| CMap ID | Pert ID | Compound Name | Targets | MoA | Compound Aliases | |
|---|---|---|---|---|---|---|
| C33104 | BRD-K96778649 | tyrphostin-47 | EGFR | EGFR inhibitor | TYRPHOSTIN-47 | Details |
| C33105 | BRD-K96779965 | BRD-K96779965 | -- | -- | -- | Details |
| C33106 | BRD-K96779993 | BRD-K96779993 | -- | -- | -- | Details |
| C33107 | BRD-K96782963 | BRD-K96782963 | -- | -- | -- | Details |
| C33108 | BRD-K96786677 | oxacillin | -- | -- | -- | Details |
| C33109 | BRD-K96787835 | BRD-K96787835 | -- | -- | -- | Details |
| C33110 | BRD-K96788889 | BRD-K96788889 | -- | -- | -- | Details |
| C33111 | BRD-K96797558 | BRD-K96797558 | -- | -- | -- | Details |
| C33112 | BRD-K96799727 | pifithrin-mu | HSPA1A; TP53 | HSP inhibitor | -- | Details |
| C33113 | BRD-K96804382 | BRD-K96804382 | -- | -- | -- | Details |
| C33114 | BRD-K96807219 | BRD-K96807219 | -- | -- | -- | Details |
| C33115 | BRD-K96809896 | SKF-86002 | -- | -- | -- | Details |
| C33116 | BRD-K96817767 | BRD-K96817767 | -- | -- | -- | Details |
| C33117 | BRD-K96831907 | BRD-K96831907 | -- | -- | -- | Details |
| C33118 | BRD-K96834095 | BRD-K96834095 | -- | -- | -- | Details |
| C33119 | BRD-K96834740 | BRD-K96834740 | -- | -- | -- | Details |
| C33120 | BRD-K96834847 | BRD-K96834847 | -- | -- | -- | Details |
| C33121 | BRD-K96839003 | BRD-K96839003 | -- | -- | -- | Details |
| C33122 | BRD-K96839270 | BRD-K96839270 | -- | -- | -- | Details |
| C33123 | BRD-K96839404 | BRD-K96839404 | -- | -- | -- | Details |
| C33124 | BRD-K96845170 | BRD-K96845170 | -- | -- | -- | Details |
| C33125 | BRD-K96855280 | BRD-K96855280 | -- | -- | -- | Details |
| C33126 | BRD-K96862998 | pirfenidone | TNF | TGF beta receptor inhibitor | -- | Details |
| C33127 | BRD-K96871778 | BRD-K96871778 | -- | -- | -- | Details |
| C33128 | BRD-K96884956 | BRD-K96884956 | -- | -- | -- | Details |
| C33129 | BRD-K96886052 | LP-99 | -- | -- | -- | Details |
| C33130 | BRD-K96893659 | BRD-K96893659 | -- | -- | -- | Details |
| C33131 | BRD-K96898856 | BRD-K96898856 | -- | -- | -- | Details |
| C33132 | BRD-K96900359 | BRD-K96900359 | -- | -- | -- | Details |
| C33133 | BRD-K96903074 | BRD-K96903074 | -- | -- | -- | Details |
| C33134 | BRD-K96903816 | BRD-K96903816 | -- | -- | -- | Details |
| C33135 | BRD-K96922741 | BRD-K96922741 | -- | -- | -- | Details |
| C33136 | BRD-K96925976 | BRD-K96925976 | -- | -- | -- | Details |
| C33137 | BRD-K96933023 | BRD-K96933023 | -- | -- | -- | Details |
| C33138 | BRD-K96935347 | BRD-K96935347 | -- | -- | -- | Details |
| C33139 | BRD-K96936751 | bretazenil | GABRA1; GABRA2; GABRA3; GABRA5 | GABA benzodiazepine site receptor partial agonist | -- | Details |
| C33140 | BRD-K96945047 | BRD-K96945047 | -- | -- | -- | Details |
| C33141 | BRD-K96945247 | BRD-K96945247 | -- | -- | -- | Details |
| C33142 | BRD-K96952717 | BRD-K96952717 | -- | -- | -- | Details |
| C33143 | BRD-K96957785 | BRD-K96957785 | -- | -- | -- | Details |
| C33144 | BRD-K96958073 | BRD-K96958073 | -- | -- | -- | Details |
| C33145 | BRD-K96968070 | BRD-K96968070 | -- | -- | -- | Details |
| C33146 | BRD-K96969336 | BRD-K96969336 | -- | -- | -- | Details |
| C33147 | BRD-K96970199 | BRD-K96970199 | -- | -- | -- | Details |
| C33148 | BRD-K96977391 | BRD-K96977391 | -- | -- | -- | Details |
| C33149 | BRD-K96977520 | BRD-K96977520 | -- | -- | -- | Details |
| C33150 | BRD-K96978561 | BRD-K96978561 | -- | -- | -- | Details |
| C33151 | BRD-K96979108 | BRD-K96979108 | -- | -- | -- | Details |
| C33152 | BRD-K96981233 | BRD-K96981233 | -- | -- | -- | Details |
| C33153 | BRD-K96987864 | BRD-K96987864 | -- | -- | -- | Details |
| C33154 | BRD-K96989541 | BRD-K96989541 | -- | -- | -- | Details |
| C33155 | BRD-K96997646 | BRD-K96997646 | -- | -- | -- | Details |
| C33156 | BRD-K97001739 | BRD-K97001739 | -- | -- | -- | Details |
| C33157 | BRD-K97006656 | BRD-K97006656 | -- | -- | -- | Details |
| C33158 | BRD-K97008061 | BRD-K97008061 | -- | -- | -- | Details |
| C33159 | BRD-K97010173 | deferasirox | CYP3A4 | Chelating agent | -- | Details |
| C33160 | BRD-K97013733 | BRD-K97013733 | -- | -- | -- | Details |
| C33161 | BRD-K97019106 | BRD-K97019106 | -- | -- | 4-acetyl-1,1-dimethylpiperazinium | Details |
| C33162 | BRD-K97024014 | BRD-K97024014 | -- | -- | -- | Details |
| C33163 | BRD-K97029281 | BRD-K97029281 | -- | -- | -- | Details |
| C33164 | BRD-K97031447 | BRD-K97031447 | -- | -- | -- | Details |
| C33165 | BRD-K97045029 | pranlukast | CYSLTR1; CYSLTR2 | Leukotriene receptor antagonist | -- | Details |
| C33166 | BRD-K97045804 | BRD-K97045804 | -- | -- | -- | Details |
| C33167 | BRD-K97048125 | BRD-K97048125 | -- | -- | -- | Details |
| C33168 | BRD-K97052218 | BRD-K97052218 | -- | -- | -- | Details |
| C33169 | BRD-K97056771 | GNF-2 | ABL1; BCR | Abl kinase inhibitor | HY-11007 | Details |
| C33170 | BRD-K97061094 | azacyclonol | -- | -- | -- | Details |
| C33171 | BRD-K97062166 | BRD-K97062166 | -- | -- | -- | Details |
| C33172 | BRD-K97064059 | BRD-K97064059 | -- | -- | -- | Details |
| C33173 | BRD-K97067262 | BRD-K97067262 | -- | -- | -- | Details |
| C33174 | BRD-K97072811 | TG-003 | CLK1; DYRK1A; CLK4; DYRK1B | CLK inhibitor | -- | Details |
| C33175 | BRD-K97073065 | BRD-K97073065 | -- | -- | -- | Details |
| C33176 | BRD-K97081185 | BRD-K97081185 | -- | -- | -- | Details |
| C33177 | BRD-K97086358 | BRD-K97086358 | -- | -- | -- | Details |
| C33178 | BRD-K97086564 | BRD-K97086564 | -- | -- | -- | Details |
| C33179 | BRD-K97095445 | BRD-K97095445 | -- | -- | -- | Details |
| C33180 | BRD-K97101532 | VX-661 | -- | -- | tezacaftor | Details |
| C33181 | BRD-K97101742 | BRD-K97101742 | -- | -- | -- | Details |
| C33182 | BRD-K97102829 | BRD-K97102829 | -- | -- | -- | Details |
| C33183 | BRD-K97103850 | BRD-K97103850 | -- | -- | -- | Details |
| C33184 | BRD-K97106314 | BRD-K97106314 | -- | -- | -- | Details |
| C33185 | BRD-K97112539 | BRD-K97112539 | -- | -- | -- | Details |
| C33186 | BRD-K97114030 | BRD-K97114030 | -- | -- | -- | Details |
| C33187 | BRD-K97116995 | BRD-K97116995 | -- | -- | -- | Details |
| C33188 | BRD-K97118047 | BRD-K97118047 | -- | -- | 4,5,6,7-tetrabromobenzotriazole | Details |
| C33189 | BRD-K97122937 | BRD-K97122937 | -- | -- | -- | Details |
| C33190 | BRD-K97128200 | BRD-K97128200 | -- | -- | -- | Details |
| C33191 | BRD-K97138361 | BRD-K97138361 | -- | -- | -- | Details |
| C33192 | BRD-K97143621 | BRD-K97143621 | -- | -- | -- | Details |
| C33193 | BRD-K97149069 | BRD-K97149069 | -- | -- | -- | Details |
| C33194 | BRD-K97157596 | BRD-K97157596 | -- | -- | -- | Details |
| C33195 | BRD-K97158071 | droperidol | DRD2 | Dopamine receptor antagonist | -- | Details |
| C33196 | BRD-K97163189 | BRD-K97163189 | -- | -- | -- | Details |
| C33197 | BRD-K97165733 | BRD-K97165733 | -- | -- | -- | Details |
| C33198 | BRD-K97166443 | BRD-K97166443 | -- | -- | -- | Details |
| C33199 | BRD-K97168035 | BRD-K97168035 | -- | -- | -- | Details |
| C33200 | BRD-K97170716 | BRD-K97170716 | -- | -- | -- | Details |
| C33201 | BRD-K97173328 | BRD-K97173328 | -- | -- | -- | Details |
| C33202 | BRD-K97175782 | BRD-K97175782 | -- | -- | -- | Details |
| C33203 | BRD-K97176469 | BRD-K97176469 | -- | -- | -- | Details |